Patients with peripheral arterial disease (PAD) frequently have functional limitations and symptoms of claudication that impact adversely on their quality of life. Many progress to critical limb ischemia requiring revascularization. Vascular inflammation and insulin resistance are two important and interdependent conditions that are associated with atherosclerosis. Moreover, both inflammation and insulin resistance cause abnormalities in vascular function and insulin resistance interferes with skeletal muscle metabolism. As such, inflammation and insulin resistance provide attractive targets for therapy that could potentially ameliorate the development of symptomatic PAD or improve the function and clinical outcomes of patients with PAD. Accordingly, the applicants propose three specific aims to determine whether inflammation and insulin resistance contribute to the functional and clinical consequences of PAD. First, a prospective, nested, case-control evaluation will be performed to test the hypothesis that baseline plasma levels of inflammatory cytokines (e.g. interleukin (IL)-4, IL-6, IL-18, macrophage inhibiting cytokine-1, CD 40 ligand) among healthy men are associated with the development of future symptomatic PAD. Second, to test the hypothesis that inflammation and insulin resistance contribute to reduced walking distance in patients with intermittent claudication by impairing vascular reactivity and skeletal muscle metabolic function, plasma markers of inflammation and insulin resistance, endothelium-dependent and independent vasodilation (by vascular ultrasonography) and skeletal muscle glucose utilization (by [18F] FDG positron emission tomography) will be measured before and after 12 weeks of treatment with rosiglitazone, atorvastatin or placebo in a 2x2 factorial design protocol. Third, to test the hypothesis that inflammation and insulin resistance are associated with the incidence and progression of vein graft disease in patients undergoing lower extremity vein bypass, functional and morphologic changes in vein grafts (measured by ultrasound and magnetic resonance imaging) will be assessed and related to inflammation and insulin resistance and to a composite clinical outcome of graft occlusion, re-intervention or major amputation. It is anticipated that the findings from this investigation will uncover novel pathophysiologic mechanisms and foster a new paradigm for the treatment of PAD.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL075771-04
Application #
7102604
Study Section
Special Emphasis Panel (ZHL1-CSR-I (S1))
Program Officer
Ershow, Abby
Project Start
2003-09-22
Project End
2008-06-30
Budget Start
2006-09-01
Budget End
2007-06-30
Support Year
4
Fiscal Year
2006
Total Cost
$945,545
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Pande, Reena L; Brown, Jonathan; Buck, Stewart et al. (2015) Association of monocyte tumor necrosis factor ? expression and serum inflammatory biomarkers with walking impairment in peripheral artery disease. J Vasc Surg 61:155-61
Gasper, Warren J; Owens, Christopher D; Kim, Ji Min et al. (2013) Thirty-day vein remodeling is predictive of midterm graft patency after lower extremity bypass. J Vasc Surg 57:9-18
Conte, Michael S; Owens, Christopher D; Belkin, Michael et al. (2013) A single nucleotide polymorphism in the p27(Kip1) gene is associated with primary patency of lower extremity vein bypass grafts. J Vasc Surg 57:1179-85.e1-2
Owens, Christopher D; Kim, Ji Min; Hevelone, Nathanael D et al. (2012) An integrated biochemical prediction model of all-cause mortality in patients undergoing lower extremity bypass surgery for advanced peripheral artery disease. J Vasc Surg 56:686-95
Hiramoto, Jade S; Owens, Christopher D; Kim, Ji Min et al. (2012) Sex-based differences in the inflammatory profile of peripheral artery disease and the association with primary patency of lower extremity vein bypass grafts. J Vasc Surg 56:387-95; discussion 395
Pillai, Padmini S; Leeson, Stanley; Porter, Timothy F et al. (2012) Chemical mediators of inflammation and resolution in post-operative abdominal aortic aneurysm patients. Inflammation 35:98-113
Conen, David; Everett, Brendan M; Kurth, Tobias et al. (2011) Smoking, smoking cessation, [corrected] and risk for symptomatic peripheral artery disease in women: a cohort study. Ann Intern Med 154:719-26
Pande, Reena L; Park, Mi-Ae; Perlstein, Todd S et al. (2011) Impaired skeletal muscle glucose uptake by [18F]fluorodeoxyglucose-positron emission tomography in patients with peripheral artery disease and intermittent claudication. Arterioscler Thromb Vasc Biol 31:190-6
Wara, Akm Khyrul; Foo, ShiYin; Croce, Kevin et al. (2011) TGF-?1 signaling and Kr├╝ppel-like factor 10 regulate bone marrow-derived proangiogenic cell differentiation, function, and neovascularization. Blood 118:6450-60
Ho, Deborah Y; Cook, Nancy R; Britton, Kathryn A et al. (2011) High-molecular-weight and total adiponectin levels and incident symptomatic peripheral artery disease in women: a prospective investigation. Circulation 124:2303-11

Showing the most recent 10 out of 32 publications